Home › Research › Tau biomarkers
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis
Agnello L, Piccoli T, Vidali M, Cuffaro L, Lo Sasso B, Iacolino G, Giglio VR, Lupo F et al.. Scandinavian journal of clinical and laboratory investigation, 2020-04-07
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
In the last decades, an important role of cerebrospinal fluid (CSF) biomarkers for Alzheimer disease (AD) diagnosis has emerged. The evaluation of the triad consisting of 42 aminoacid-long amyloid-beta peptide (Aβ42), total Tau (tTau) and Tau phosphorylated at threonine 181 (pTau) have been recently integrated into the research diagnostic criteria of AD. For a long time, the enzyme-linked immunosorbent assay (ELISA) has represented the most commonly used method for the measurement of CSF biomarkers levels.
What this study adds
Evidence grade: Low
The record lists 96 participants. This study assessed how accurately cerebrospinal fluid amyloid-beta 42, total tau and phosphorylated tau, measured by a chemiluminescent enzyme immunoassay, diagnose Alzheimer disease. It concerns diagnostic testing and does not evaluate any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Agnello, L., Piccoli, T., Vidali, M., Cuffaro, L., Lo Sasso, B., Iacolino, G., et al. (2020). Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis. Scandinavian journal of clinical and laboratory investigation. https://doi.org/10.1080/00365513.2020.1740939
Vancouver
Agnello L, Piccoli T, Vidali M, Cuffaro L, Lo Sasso B, Iacolino G, et al. Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis. Scandinavian journal of clinical and laboratory investigation. 2020. doi:10.1080/00365513.2020.1740939. PMID: 32255379.
BibTeX
@article{agnello2020-32255379,
author = {Agnello, L. and Piccoli, T. and Vidali, M. and Cuffaro, L. and Lo Sasso, B. and Iacolino, G. and Giglio, V. R. and Lupo, F. and others},
title = {{Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis}},
journal = {Scandinavian journal of clinical and laboratory investigation},
year = {2020},
doi = {10.1080/00365513.2020.1740939},
pmid = {32255379},
url = {https://doi.org/10.1080/00365513.2020.1740939}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The evaluation of the triad consisting of 42 aminoacid-long amyloid-beta peptide (Aβ42), total Tau (tTau) and Tau phosphorylated at threonine 181 (pTau) have been recently integrated into the research diagnostic criteria of AD.
- For a long time, the enzyme-linked immunosorbent assay (ELISA) has represented the most commonly used method for the measurement of CSF biomarkers levels.
- This study aimed to assess the diagnostic accuracy of CSF biomarkers, namely Aβ42, tTau and pTau and their ratio, measured by fully automated CLEIA assay (Lumipulse).
- We included 96 patients clinically diagnosed as AD (48) and non-AD (48).
Why it matters
This study assessed how accurately cerebrospinal fluid amyloid-beta 42, total tau and phosphorylated tau, measured by a chemiluminescent enzyme immunoassay, diagnose Alzheimer disease. It concerns diagnostic testing and does not evaluate any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants96
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Scandinavian journal of clinical and laboratory investigation) |
| Journal's citation record | 2 / 4 | Scandinavian Journal of Clinical and Laboratory Investigation: journal h-index 154 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 1 / 4 | 96 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 46 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.8 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 3 / 6 | Cited 5.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Marcello Ciaccio: h-index 46 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Palermo: institution h-index 473 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32255379) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.